Cargando…

Risk of Ischemic Cerebrovascular and Coronary Events in Adult Users of Anticonvulsant Medications in Routine Care Settings

BACKGROUND: Older‐generation anticonvulsants that highly induce cytochrome P450 enzyme system activity produce metabolic abnormalities that may increase cardiovascular risk. The objective of this study was to evaluate the risk of ischemic cerebrovascular and coronary events in adult new users of ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patorno, Elisabetta, Glynn, Robert J., Hernandez‐Diaz, Sonia, Avorn, Jerry, Wahl, Peter M., Bohn, Rhonda L., Mines, Daniel, Liu, Jun, Schneeweiss, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828795/ https://www.ncbi.nlm.nih.gov/pubmed/23900213 http://dx.doi.org/10.1161/JAHA.113.000208

Ejemplares similares

Preconditioning by Preceding Ischemic Cerebrovascular Events
por: Correia, Pamela N., et al.
Publicado: (2021)

Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments
por: Schneeweiss, Sebastian, et al.
Publicado: (2021)

COMPARATIVE PERFORMANCE OF FOUR CLAIMS-BASED FRAILTY MEASURES IN THE UNITED STATES MEDICARE DATA
por: Kim, Dae H, et al.
Publicado: (2019)

A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes
por: Fralick, Michael, et al.
Publicado: (2021)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
por: Liu, Shimeng, et al.
Publicado: (2021)

Platelet function, coagulation and fibrinolysis in patients with previous coronary and cerebrovascular ischemic events
por: Barbosa, Carlos José Dornas Gonçalves, et al.
Publicado: (2019)

The use of dual antiplatelet therapy for ischemic cerebrovascular events
por: Mele, Francesco, et al.
Publicado: (2022)

Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study
por: Fralick, Michael, et al.
Publicado: (2020)

Effect of ASA on the risk of cerebrovascular ischemic events in patients with PFO
por: Xu, Liang, et al.
Publicado: (2022)

Ischemic and Hemorrhagic Cerebrovascular Events Related to COVID-19 Coagulopathy and Hypoxemia
por: Sojka, Michał, et al.
Publicado: (2022)

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
por: Patorno, Elisabetta, et al.
Publicado: (2018)

Association Between Carotid Artery Perivascular Fat Density and Cerebrovascular Ischemic Events
por: Baradaran, Hediyeh, et al.
Publicado: (2018)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events
por: Wang, Anxin, et al.
Publicado: (2021)

Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning
por: Liu, Shi-Meng, et al.
Publicado: (2018)

Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
por: Barbosa, Carlos J.D.G., et al.
Publicado: (2019)

Endovascular treatment of cerebrovascular stenosis with stent for patients with ischemic cerebrovascular disease
por: Lin, Kailong, et al.
Publicado: (2020)

Risk factors of short-term stroke recurrence in patients with minor ischemic cerebrovascular events
por: Ghandehari, Kavian, et al.
Publicado: (2013)

The role of endothelial progenitor cells in transient ischemic attack patients for future cerebrovascular events
por: Meamar, Rokhsareh, et al.
Publicado: (2016)

Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study
por: Patorno, Elisabetta, et al.
Publicado: (2014)

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care
por: Patorno, Elisabetta, et al.
Publicado: (2019)

Carotid Atherosclerosis in Ischemic Cerebrovascular Patients
por: Zhang, Ai Juan, et al.
Publicado: (2009)

Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021)

Pregnancy, epilepsy, and anticonvulsants
por: Steinhoff, Bernhard J
Publicado: (2008)

Substitution of anticonvulsant drugs
por: Steinhoff, Bernhard J, et al.
Publicado: (2009)

Neuropsychological Effects of Anticonvulsants
por: Morgan, Lindsey, et al.
Publicado: (2015)

Clinicians’ Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation
por: Kesselheim, Aaron S., et al.
Publicado: (2014)

Intraplaque Stretch in Carotid Atherosclerotic Plaque – an Effective Biomechanical Predictor for Subsequent Cerebrovascular Ischemic Events
por: Teng, Zhongzhao, et al.
Publicado: (2013)

Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study
por: Park, Yoonyoung, et al.
Publicado: (2018)

The impact of P2Y12 promoter DNA methylation on the recurrence of ischemic events in Chinese patients with ischemic cerebrovascular disease
por: Li, Xin-Gang, et al.
Publicado: (2016)

Advances in endovascular therapy for ischemic cerebrovascular diseases
por: Lu, Jun, et al.
Publicado: (2016)

Ischemic cerebrovascular diseases in patients with COVID-19
por: El Aoud, S., et al.
Publicado: (2021)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Anticonvulsant drugs in bipolar disorder
por: Grunze, Heinz, et al.
Publicado: (1999)

The effectiveness of anticonvulsants in psychiatric disorders
por: Grunze, Heinz C. R.
Publicado: (2008)

Anticonvulsant drugs in migraine prophylaxis
por: Frediani, Fabio, et al.
Publicado: (2001)

PSYCHOSES ASSOCIATED WITH ANTICONVULSANT TOXICITY
por: Bhatia, M.S., et al.
Publicado: (1988)

Anticonvulsant Medications in Mitochondrial Disease
por: Mithal, Divakar S., et al.
Publicado: (2017)

Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments
por: Schneeweiss, Sebastian, et al.
Publicado: (2012)

Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model
por: Lee, Moa P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n20f11s3ihg1fvd88fqa1ige92